Pancreatic Adenosquamous Carcinoma
7 clinical trials · Condition
◉ Watch Pancreatic Adenosquamous Carcinoma
| Record | Firm | Date |
|---|---|---|
| APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation (NCT04858334) | National Cancer Institute (NCI) | 2021-06-22 |
| Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma (NCT04157127) | Diakonos Oncology Corporation | 2020-08-03 |
| Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma (NCT07573215) | Revolution Medicines, Inc. |
Track Pancreatic Adenosquamous Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.